Axon Enterprise, Inc $AXON Shares Bought by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 831,177 shares of the biotechnology company’s stock after buying an additional 102,025 shares during the period. Axon Enterprise comprises about 2.0% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 8th largest holding. Westfield Capital Management Co. LP’s holdings in Axon Enterprise were worth $472,051,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $28,000. New Millennium Group LLC acquired a new position in shares of Axon Enterprise during the third quarter worth about $29,000. Sound Income Strategies LLC boosted its position in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares during the period. Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $30,000. Finally, Lodestone Wealth Management LLC acquired a new position in shares of Axon Enterprise during the fourth quarter worth about $35,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

AXON opened at $513.20 on Friday. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91. The firm has a market capitalization of $41.36 billion, a PE ratio of 206.10, a PEG ratio of 8.75 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27. The business’s 50-day simple moving average is $407.52 and its 200 day simple moving average is $491.96.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The business had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. During the same quarter in the prior year, the company posted $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% on a year-over-year basis. As a group, sell-side analysts expect that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on AXON. TD Cowen reduced their price objective on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Piper Sandler reduced their price objective on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating for the company in a research report on Thursday, May 7th. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 19th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Finally, Robert W. Baird set a $800.00 target price on Axon Enterprise in a report on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Insiders Place Their Bets

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the sale, the insider owned 52,813 shares in the company, valued at $21,125,200. This represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 629 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $469.64, for a total value of $295,403.56. Following the completion of the sale, the director owned 1,141 shares in the company, valued at $535,859.24. This represents a 35.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 3,548 shares of company stock worth $1,542,775 over the last ninety days. 4.20% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.